Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyEmblemHealth investigational technologies Coverage…
    Ask Trek AI about this page
    CurrentEmblemHealthPolicy N/A

    Investigational or Unproven Medical Technologies

    Customize your policy alerts

    Sign up for all EmblemHealth policy alerts

    Know when EmblemHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines EmblemHealth's positions on investigational or unproven procedures, devices, and laboratory tests and lists technologies with their investigational/coverage status; affects providers submitting requests or claims to EmblemHealth.

    Policy Summary
    PayerEmblemHealth
    PolicyInvestigational or Unproven Medical Technologies
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit pre-certification/prior authorization requests for listed investigational or HDE devices and technologies for case-by-case review.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    June 2026
    document/version date
    scalp cooling, TMS, gene profilingsample technologies
    dozenscodes referenced
    FEHBP & HDEspecial program notes

    Coverage Criteria — Investigational / Not Medically Necessary

    Scalp cooling — not separately reimbursed

    General coverage stance for scalp cooling and similar products:

    Scalp cooling products: Cooling caps and other products for scalp cooling are considered incidental to the chemotherapy administration and are not separately reimbursed; products purchased by the member are generally excluded as supplies under plans that exclude supplies.

    CPT 0662T, 0663T; HCPCS E0218, E0236 listed

    Molecular testing — payer-specific coverage notes

    Gene expression profiling and proprietary PLA codes:

    Proprietary PLA codes for Medicaid: Proprietary lab analysis (PLA) codes (those ending with 'U') are not covered for Medicaid members, as they are not reimbursed by NYS Medicaid.

    Examples: 0046U, 0049U, 0050U

    Specific gene tests listed: Gene expression profiling for acute myeloid leukemia (AML) for therapeutic management lists specific tests including NPM1 (CPT 81310), CEBPA (CPT 81218), FLT3 (CPT 81245, 81246), RUNX1 (CPT 81334), and genomic sequence analysis panels (CPT 81450); payer-specific coverage distinctions apply (commercial vs Medicaid).

    See CPT rows and NGS/Molecular Pathology LCD references

    HDE devices — case-by-case review

    Devices approved under HDE or requiring case-by-case review:

    HDE devices (case-by-case review): Devices approved under a Humanitarian Device Exemption (HDE) (e.g., AbioCor®, Reclaim™ DBS) may be listed but pre-certification requests will be reviewed on a case-by-case basis; Medicare/NCD rules may create payment exceptions for Medicare beneficiaries enrolled in qualifying clinical studies.

    CPT examples: 33927-33929, L8698, 21499, 61863-61888, 95961-95962; HCPCS L8680-L8689

    Investigational / Unproven Designations

    Technologies and indications listed below are considered investigational or unproven:

    Transcranial magnetic stimulation (TMS) for neurologic or psychological indications other than depression: TMS for indications such as migraines, strokes, obsessive compulsive disorder, Parkinson's disease, dystonia, tinnitus, auditory hallucinations, and other non-depression uses is designated investigational/unproven.

    CPT codes 90867-90869 referenced.

    Tremor analysis devices: Physiologic recording of tremor using accelerometers and similar devices are listed as investigational/unproven.

    Example CPT codes 0778T, 95999.

    Vagus nerve stimulation (VNS): VNS is considered investigational for most indications (e.g., addictions, Alzheimer disease, anxiety, atrial fibrillation, autism spectrum disorders, back pain, bipolar disorder, cerebral palsy, chronic pain, eating disorders, headaches, cognitive impairment associated with Alzheimer's disease, coma, essential tremor, fibromyalgia, heart failure, impaired glucose tolerance, morbid obesity, narcolepsy, neck pain, obsessive compulsive disorder, paralysis agitans, sleep disorder, stroke, tinnitus, Tourette's, traumatic brain injury, and others).

    Cooling caps and other scalp cooling products are considered incidental to chemotherapy administration and are not separately reimbursed. Items purchased directly by the member (e.g., scalp cooling caps or related supplies) are treated as supplies and are generally excluded from coverage under plans that exclude supplies. Relevant example codes include CPT 0662T, 0663T and HCPCS E0218, E0236.

    Proprietary lab analysis (PLA) codes — those ending with the letter 'U' (PLA/'U' codes) — are not covered for Medicaid members because NYS Medicaid does not reimburse these proprietary PLA codes. Examples of PLA codes referenced in the gene expression profiling rows include 0046U, 0049U, 0050U.

    Vagus nerve stimulation (VNS) is designated investigational for most indications listed in the database (for example: addictions, Alzheimer disease, anxiety, atrial fibrillation, autism spectrum disorders, chronic pain, headache disorders, essential tremor, and many others). However, VNS is explicitly not considered investigational for epilepsy (see MCG #A-0424) and has a Medicare-specific allowance for Treatment Resistant Depression (TRD) under the Medicare NCD via Coverage with Evidence Development (CED). Providers submitting requests for VNS should reference applicable NCD/MCG policy identifiers and the related CPT/HCPCS device codes listed in the policy when documenting exceptions.

    The policy lists multiple examples of procedures and devices that are designated investigational or otherwise require case-specific review. Examples include: cryoablation for chronic rhinitis (unlisted CPT examples 30999, 31299), various applications of transcranial magnetic stimulation (TMS) for neurologic or psychological indications other than depression (CPT 90867–90869), tremor analysis devices (e.g., physiologic tremor recordings using accelerometers, CPT 0778T, 95999), and other miscellaneous unlisted procedure codes used for emerging therapies. These entries are intended to alert providers that such services are generally considered investigational for the enumerated indications.

    Technologies and indications listed as investigational or unproven in this document are considered not medically necessary / non-covered when billed for those specified indications. Specific examples called out include: transcranial magnetic stimulation (TMS) for non-depression indications (CPT 90867–90869), tremor analysis devices (CPT 0778T, 95999), vagus nerve stimulation for indications other than epilepsy or Medicare TRD (multiple CPT/HCPCS and implant/device codes listed), and venoplasty for relapsing remitting multiple sclerosis (CPT 36901–36906).

    Covered Indications and Specific Tests

    Gene expression profiling for AML and related therapeutic management — specific gene tests and payer notes

    Gene expression profiling (AML) - covered tests: Gene expression profiling for acute myeloid leukemia (AML) for therapeutic management identifies specific gene tests included in the database: NPM1 (CPT 81310), CEBPA (CPT 81218), FLT3 (CPT 81245, 81246), RUNX1 (CPT 81334), and genomic sequence analysis panels (CPT 81450).

    Coverage may vary by payer; proprietary PLA ('U') codes are not covered for Medicaid members.

    Coding — CPT / HCPCS / Device Codes

    Scalp cooling — incidental / not separately reimbursedmixedNot Covered
    0662TScalp cooling (example PLA/T code listed)
    0663TScalp cooling (example PLA/T code listed)
    E0218HCPCS code referenced for scalp cooling products
    E0236HCPCS code referenced for scalp cooling products
    Device and procedure CPT/HCPCS codes referenced in database rowsmixed
    33927CPT listed with AbioCor® device row
    33928CPT listed with AbioCor® device row
    33929CPT listed with AbioCor® device row
    L8698HCPCS L-code listed with AbioCor® device row
    21499CPT used in DBS/other device entries
    61863CPT DBS procedure codes
    61864CPT DBS procedure codes
    61867CPT DBS procedure codes
    61885CPT DBS procedure codes
    61886CPT DBS procedure codes
    1–10 of 24
    1/3
    Molecular pathology / gene expression profiling codesmixed
    0046UProprietary lab analysis (PLA) code for gene expression profiling
    0049UProprietary lab analysis (PLA) code for gene expression profiling
    0050UProprietary lab analysis (PLA) code for gene expression profiling
    81310NPM1
    81218CEBPA
    81245FLT3
    81246FLT3
    81450Genomic sequence analysis panels
    81334RUNX1 gene expression profiling
    Miscellaneous procedure/unlisted CPT codes referencedCPT
    92227Tele-retinal imaging / diabetic retinopathy telescreening code
    30999Cryoablation - rhinitis (unlisted CPT examples)
    31299Cryoablation - rhinitis (unlisted CPT examples)
    0778TTremor analysis device CPT
    95999Unlisted neurology code used for tremor analysis device
    67299Transpupillary thermotherapy for retinoblastoma (unlisted)
    90867TMS boost codes (psychiatric)
    90868TMS codes
    90869TMS codes
    38999Surgical interventions for lymphedema (unlisted)
    1–10 of 12
    1/2
    Transcranial Magnetic Stimulation (non-depression indications)CPTNot Covered
    90867Transcranial magnetic stimulation (TMS) codes referenced for neurologic or psychological indications other than depression
    90868Transcranial magnetic stimulation (TMS)
    90869Transcranial magnetic stimulation (TMS)
    Transpupillary thermotherapyCPTCovered
    67299Transpupillary thermotherapy for retinoblastoma (unlisted procedure, retina/vitreous)
    Tremor analysis deviceCPTNot Covered
    0778TPhysiologic recording of tremor using accelerometers (example code listed)
    95999Unlisted neurologic procedure (example for tremor analysis device)
    Vagus nerve stimulation and related neurostimulation codesCPTNot Covered
    0312TVagus nerve stimulation service code
    0313TVagus nerve stimulation service code
    0314TVagus nerve stimulation service code
    0315TVagus nerve stimulation service code
    0316TVagus nerve stimulation service code
    0317TVagus nerve stimulation service code
    61885Insertion or revision of cranial neurostimulator lead (listed among VNS-related codes)
    61886Related neurostimulation code
    61888Related neurostimulation code
    64553Insertion or replacement of peripheral neurostimulator lead
    1–10 of 17
    1/2
    HCPCS/device codes (VNS, gammaCore, implantable device codes)HCPCSNot Covered
    E1399Unclassified miscellaneous HCPCS (report for gammaCore Sapphire)
    K1020HCPCS code referenced for device
    L8680Prosthetic implantable device codes referenced
    L8681Prosthetic implantable device codes referenced
    L8682Prosthetic implantable device codes referenced
    L8683Prosthetic implantable device codes referenced
    L8684Prosthetic implantable device codes referenced
    L8685Prosthetic implantable device codes referenced
    L8686Prosthetic implantable device codes referenced
    L8687Prosthetic implantable device codes referenced
    1–10 of 12
    1/2
    Venoplasty for relapsing remitting multiple sclerosisCPTNot Covered
    36901Venous angioplasty, initial venous access/catheterization codes listed for venoplasty
    36902Venous angioplasty code
    36903Venous angioplasty code
    36904Venous angioplasty code
    36905Venous angioplasty code
    36906Venous angioplasty code
    HUD patient population threshold
    HUD patient population thresholdHumanitarian Use Device (HUD) defined as intended to benefit patients with a disease or condition that affects or is manifested in not more than 8,000 individuals in the United States per year
    HDE marketing application definitionHumanitarian Device Exemption (HDE) is a marketing application for a HUD that is exempt from certain FDA effectiveness requirements and is subject to profit and use restrictions
    Regulatory change noteThreshold previously 4,000 individuals; increased to 8,000 on June 7, 2017
    Exceptions for Vagus Nerve Stimulation (Epilepsy, TRD via Medicare NCD/CED)

    Provider Actions — Authorization, Documentation, Billing

    Prior Authorization

    Pre-certification required — case-by-case review for HDE/investigational devices

    Pre-certification requests for devices or technologies listed as investigational or approved under a Humanitarian Device Exemption (HDE) will be reviewed on a case-by-case basis; Medicare member exceptions related to NCD rules may apply. Submit pre-certification/prior authorization for listed device CPT/HCPCS codes when applicable.

    • Example codes: 33927, 33928, 33929, L8698 (AbioCor® HDE) — review on a case-by-case basis
    • Reclaim™ DBS (HDE) entries likewise require case-by-case pre-certification review
    Billing Rule

    Prior authorization and coding alert — investigational/unproven procedure codes

    Ordering Requirements and Program Routing

    Note

    ORDERING REQUIREMENTS — transplant services routed through EmblemHealth transplant program

    Transplant-related orders and requests must be routed through the EmblemHealth transplant program; all transplant services are reviewed with the assigned transplant program medical director.

    • Contact the transplant case management program at 1-800-447-0768 to initiate referral or request services.

    Not Covered — Specific Exclusions

    Proprietary PLA codes (PLA/'U' codes) are not covered for Medicaid members per NYS Medicaid reimbursement rules. This exclusion applies to proprietary PLA codes referenced in gene expression profiling rows (examples: 0046U, 0049U, 0050U); providers should reference the commercial and Medicaid distinctions shown in the coding rows when submitting claims.

    Cooling caps and other scalp cooling products used in association with chemotherapy are considered incidental to the chemotherapy administration and are not separately reimbursed. Items purchased by the member are treated as supplies and are generally excluded from coverage under plans that exclude supplies. Relevant example codes include CPT 0662T, 0663T and HCPCS E0218, E0236.

    The database lists tremor analysis devices (e.g., physiologic tremor recording using accelerometers, CPT examples 0778T, 95999) and venoplasty for relapsing remitting multiple sclerosis (CPT 36901–36906) as investigational/unproven; these are designated not covered for the specified indications when billed for those uses.

    Definitions and Key

    Humanitarian Device Exemption (HDE) definition
    HDE definitionA Humanitarian Device Exemption (HDE) is a marketing application for a Humanitarian Use Device (HUD) that is exempt from the effectiveness requirements of Sections 514 and 515 of the FD&C Act
    HUD definitionA Humanitarian Use Device (HUD) is intended to benefit patients with a disease or condition that affects or is manifested in not more than 8,000 individuals in the U.S. per year
    RestrictionsHDEs are subject to certain profit and use restrictions
    Key (Y/N) — interpretation of Y and N
    Y meaningY = Yes (not investigational)
    N meaningN = No (denotes investigational unless indicated otherwise)

    Background and Scope

    This document summarizes EmblemHealth's positions on investigational or unproven technologies, noting which procedures, devices, and laboratory tests are considered investigational (designated 'N') or allowed (designated 'Y') and identifying payer-specific exceptions. It also references special program notes including Humanitarian Device Exemption (HDE) guidance and transplant case management review processes, and provides associated CPT/HCPCS codes for the listed technologies. The Medical Technologies Database serves as the operational reference for prior authorization, claims adjudication, and provider guidance.

    Revision History

    2026-06version

    Medical Technologies Database version published (June 2026) reflecting current investigational and coverage designations.

    2026-06-01effective_date

    Policy effective date set to 2026-06-01 for the Medical Technologies Database.

    2026-05-08content_update

    Gene expression profiling (AML) therapeutic management row updated; CPT and PLA code notes and Medicaid PLA ('U') coverage guidance referenced (entry dated 5/8/2026).

    Policy Summary
    PayerEmblemHealth
    PolicyInvestigational or Unproven Medical Technologies
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit pre-certification/prior authorization requests for listed investigational or HDE devices and technologies for case-by-case review.
    SourceLink
    On This Page
    Coverage Criteria — Investigational / Not Medically NecessaryCovered Indications and Specific TestsCoding — CPT / HCPCS / Device CodesProvider Actions — Authorization, Documentation, BillingOrdering Requirements and Program RoutingNot Covered — Specific ExclusionsDefinitions and KeyBackground and ScopeRevision History

    Exception: VNS is not investigational for epilepsy (see MCG #A-0424) and has TRD coverage nuances for Medicare per NCD/CED; CPT and HCPCS codes listed.

    Venoplasty for relapsing remitting multiple sclerosis is listed as investigational/unproven.

    CPT codes 36901-36906 referenced.

    VNS exceptions - epilepsyVagus nerve stimulation is not considered investigational for epilepsy (see MCG #A-0424)
    VNS exceptions - TRD for MedicareTreatment Resistant Depression (TRD) covered for Medicare members per NCD through Coverage with Evidence Development (CED)
    Coding references for exceptionsApplicable CPT (e.g., 0312T–0317T, 61885, 61886, 61888, 64553, 64568–64595, 95970) and HCPCS codes (e.g., E1399 report for gammaCore, K1020, L8680–L8689) are listed in the database rows

    Certain CPT/HCPCS codes listed in the database are associated with procedures designated investigational or unproven and may require prior authorization or may be non-covered when billed for the listed indications.

    • Examples include TMS codes (90867–90869), tremor analysis codes (0778T, 95999), VNS and related codes (0312T–0317T, 61885, 64553, 95970), and venoplasty codes (36901–36906).
    • Obtain prior authorization for these codes when submitting for the listed indications to avoid potential denial.
    Step Therapy

    Step/coverage sequencing for molecular tests — PLA 'U' codes not covered for Medicaid

    For molecular testing and gene expression profiling, note that proprietary PLA codes ending in 'U' are not covered for Medicaid members per NYS Medicaid rules; confirm payer-specific coverage and sequencing before ordering.

    • Example PLA codes: 0046U, 0049U, 0050U — not covered for Medicaid members
    • Confirm commercial vs Medicaid coverage for NPM1 (81310), CEBPA (81218), FLT3 (81245/81246), RUNX1 (81334) prior to testing
    Note

    Placeholder — no provider action specified

    (No requirement text available in source for this placeholder.)

    Documentation Required

    Transplant case management review — submit to transplant program for medical director review

    All requested transplant services must be submitted to the EmblemHealth transplant program and will be reviewed for medical necessity with the medical director assigned to the transplant case management program; contact the transplant program to request case management services.

    • Contact number for transplant case management: 1-800-447-0768
    • Evidence-based criteria and medical necessity reviews are applied to all transplant service requests
    Documentation Required

    Documentation for exceptions — cite applicable NCD/CED or coverage policy

    When an exception is noted (for example VNS for epilepsy or TRD under Medicare NCD/CED), providers should reference the applicable NCD/MCG policy identifiers and supporting documentation when submitting claims or prior authorization requests.

    • VNS is not investigational for epilepsy (see MCG #A-0424) and TRD coverage for Medicare is per NCD with CED — cite the applicable NCD/CED when submitting
    • Include references to the applicable policy or NCD/CED documentation in the request
    Denial Risk

    Denial risk — scalp cooling products are incidental to chemotherapy and not separately reimbursed

    Cooling caps and other scalp cooling products are considered incidental to chemotherapy and are not separately reimbursed; items purchased by the member are treated as supplies and generally excluded from coverage.

    • Example codes: CPT 0662T, 0663T; HCPCS E0218, E0236 — expect denial or nonpayment if billed separately
    • Do not bill scalp cooling devices separately when provided incident to chemotherapy
    Denial Risk

    Denial risk — investigational/unproven services may be denied or not covered

    Claims for technologies and procedures listed as investigational or unproven for the specified indications risk denial as not medically necessary when billed for those indications; verify coverage stance and obtain prior authorization where applicable.

    • Examples of high denial risk items: TMS for non-depression indications (90867–90869), VNS for most indications (0312T–0317T, related HCPCS), tremor analysis devices (0778T, 95999), venoplasty for RRMS (36901–36906).
    • Provide thorough clinical justification and prior authorization paperwork to reduce denial risk; absent coverage criteria, claims may be denied.
    Key usageKey applied in database rows to indicate investigational status (Y/N) for listed technologies and indications
    Vagus nerve stimulation (VNS) definition and exception note
    VNS definitionVagus nerve stimulation (VNS) is neurostimulation therapy delivered via an implanted or external device
    Investigational stanceVNS is considered investigational for most indications listed in the database (e.g., addiction, Alzheimer disease, chronic pain, tinnitus, TBI, etc.)
    Explicit exceptionsExceptions noted: epilepsy (MCG #A-0424) and Medicare TRD coverage via NCD/CED
    Venoplasty for relapsing remitting multiple sclerosis definition
    Procedure definitionVenoplasty for relapsing remitting multiple sclerosis is endovascular dilation of veins proposed as a treatment for MS
    Coverage stanceListed as investigational/unproven in this document and designated not covered for the listed indications
    Coding referencesAssociated CPT codes: 36901, 36902, 36903, 36904, 36905, 36906
    2026-04-10content_update

    Laser interstitial thermotherapy (LITT) entries updated with review note dated 4/10/2026 marking investigational status for specified indications.

    2026-03-13content_update

    Deep brain stimulation (Reclaim™ DBS™ Therapy) and several gene expression profiling rows annotated with review entries dated 3/13/2026; venoplasty row also records 3/13/2026 in database.

    2025-11-14content_update

    Multiple items (e.g., spinal vertebral stapling, certain tele-retinal imaging entries, tremor/VNS rows) updated with review date 11/14/2025 reflecting investigational determinations.

    2025-09-12content_update

    Microwave thermotherapy and select nasal endoscopy/balloon dilation entries updated with review date 9/12/2025.

    2025-08-08content_update

    RUNX1 gene expression profiling row updated with review date 8/8/2025 documenting coverage notes for that gene test.

    2024-06-07regulatory_note

    Humanitarian Use Device (HUD) population threshold noted to have increased to 8,000 individuals per year (June 7, 2017) and referenced in HDE guidance within the database.

    2026-05-08coding_update

    Coding row notes include PLA ('U') code noncoverage for Medicaid members per NYS Medicaid reimbursement guidance (entry referenced 5/8/2026).

    2026-06-01record_statusLatest

    Document status recorded as CURRENT with effective date and Medical Technologies Database (June 2026) versioning.